Clinical Drug Experience Knowledgebase

urea (3 trials)

vincristine (oncovin) (3 trials)

asparaginase (elspar) (2 trials)

cyclophosphamide (cytoxan) (2 trials)

cytarabine (cytosar-u) (2 trials)

daunorubicin (cerubidine) (2 trials)

doxorubicin (Doxil) (1 trial)

etoposide (vepesid) (2 trials)

ifosfamide (ifex) (1 trial)

mercaptopurine (purinethol) (2 trials)

naltrexone (revia) (2 trials)

prednisone (meticorten) (2 trials)

retinoic acid (1 trial)

tioguanine (Lanvis) (2 trials)

tretinoin (Retin-A) (2 trials)

arsenic trioxide (trisenox) (1 trial)

gemtuzumab ozogamicin (mylotarg) (1 trial)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

autologous umbilical cord blood (1 trial)

busulfan (myleran) (1 trial)

cyclosporine (sandimmune) (1 trial)

leucovorin (1 trial)

melphalan (alkeran) (1 trial)

mitoxantrone (novantrone) (1 trial)

pegaspargase (oncaspar) (1 trial)